glp-1 drugs and fatty liver Why are agonists being used to treat patients with nonalcoholic disease? Multiple target tissue effects of

Description

Zhong Q, Bollag RJ, Dransfield DT, et al

Glycaemic control typically improves within the first few weeks, whilst significant weight loss and associated energy improvements may take 3-6 months to become apparent

With a projected launch in 2026, it represents Eli Lillys bid to expand the companys dominance in the GLP-1R category. China-based Jiangsu Hengruis HRS-9531 is the final Phase III contender and the only one not being developed by pharma giants Novo Nordisk or Eli Lilly

2017;2(14):e93751

What a Doctor May Assess A doctor-led weight management approach may include: Medical consultation Blood tests if needed HbA1c and metabolic health review Weight management treatment options Dose guidance and follow-up Support for side effects and long-term results If you feel like you have been trying to lose weight but your body is not responding, it may be time to understand what is happening medically